UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.

UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.

Pancreatic ductal adenocarcinoma is an aggressive form of pancreatic cancer and the fourth leading cause of cancer-related death. When possible, curative approaches are based on surgical resection, though not every patient is a candidate for surgery. There are clinical guidelines for the management...

Full description

Bibliographic Details
Main Authors: Javier Martinez-Useros, Tihomir Georgiev-Hristov, María Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Alberto Indacochea, Santiago Guerrero, Weiyao Li, Arancha Cebrián, Teresa Gómez Del Pulgar, Alberto Puime-Otin, Laura Del Puerto-Nevado, María Rodríguez-Remírez, Nuria Pérez, Angel Celdrán, Fátima Gebauer, Jesus Garcia-Foncillas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5538752?pdf=render

Internet

http://europepmc.org/articles/PMC5538752?pdf=render

Similar Items